BR9908825A - Forma cristalina de paroxetina - Google Patents
Forma cristalina de paroxetinaInfo
- Publication number
- BR9908825A BR9908825A BR9908825-8A BR9908825A BR9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A
- Authority
- BR
- Brazil
- Prior art keywords
- paroxetine
- crystalline form
- free
- crystalline
- therapy
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 3
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960002296 paroxetine Drugs 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"FORMA CRISTALINA DE PAROXETINA" Base livre de paroxetina pura, cristalina, por exemplo, e isenta de solvente; e o seu emprego na terapia para tratar depressão.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
| GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
| GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
| PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9908825A true BR9908825A (pt) | 2000-11-21 |
Family
ID=27269245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9908825-8A BR9908825A (pt) | 1998-03-16 | 1999-03-16 | Forma cristalina de paroxetina |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1064282A1 (pt) |
| JP (1) | JP2002506865A (pt) |
| KR (1) | KR20010041947A (pt) |
| CN (1) | CN1300286A (pt) |
| AP (1) | AP2000001907A0 (pt) |
| AU (1) | AU2847199A (pt) |
| BG (1) | BG104839A (pt) |
| BR (1) | BR9908825A (pt) |
| CA (1) | CA2323896A1 (pt) |
| EA (1) | EA200000946A1 (pt) |
| HU (1) | HUP0101215A3 (pt) |
| ID (1) | ID27596A (pt) |
| IL (1) | IL138390A0 (pt) |
| NO (1) | NO20004583L (pt) |
| PL (1) | PL342931A1 (pt) |
| SK (1) | SK13622000A3 (pt) |
| TR (1) | TR200002675T2 (pt) |
| WO (1) | WO1999047519A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
-
1999
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Withdrawn
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Ceased
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG104839A (en) | 2001-09-28 |
| EP1064282A1 (en) | 2001-01-03 |
| SK13622000A3 (sk) | 2001-03-12 |
| WO1999047519A1 (en) | 1999-09-23 |
| CN1300286A (zh) | 2001-06-20 |
| PL342931A1 (en) | 2001-07-16 |
| AP2000001907A0 (en) | 2000-09-30 |
| TR200002675T2 (tr) | 2000-12-21 |
| IL138390A0 (en) | 2001-10-31 |
| KR20010041947A (ko) | 2001-05-25 |
| EA200000946A1 (ru) | 2001-02-26 |
| NO20004583D0 (no) | 2000-09-14 |
| HUP0101215A3 (en) | 2002-05-28 |
| JP2002506865A (ja) | 2002-03-05 |
| CA2323896A1 (en) | 1999-09-23 |
| ID27596A (id) | 2001-04-12 |
| AU2847199A (en) | 1999-10-11 |
| NO20004583L (no) | 2000-09-15 |
| HUP0101215A2 (hu) | 2002-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0314603A (pt) | Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos | |
| PT1143967E (pt) | Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas | |
| ATE331534T1 (de) | Anwendung von zielgerichtetem radium 223 für palliative und therapeutische behandlung von knochenkrebs | |
| BR0014078A (pt) | Inibidores de fator xa | |
| BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| AR004321A1 (es) | Empleo de epinastina para el tratamiento de dolores. | |
| AR025964A1 (es) | Tratamiento nasal topico | |
| BR9912376A (pt) | Sais de nitrato, composições farmacêuticas, udo de sais e composições, e, processo para preparação de sais de nitrato. | |
| PT777482E (pt) | Composicao de combinacao para utilizacao em doencas imunologicas | |
| BR0113925A (pt) | Derivados de ácido 2-amino-2-alquil-5 heptenóico e heptinóico úteis como inibidores da sintase de óxido nìtrico | |
| SE9802208D0 (sv) | Novel compounds | |
| BR9909118A (pt) | Composição farmacêutica, comprimido, forma de dosagem unitária farmacêutica sólida estável, e, processo para tratar depressão em um mamìfero | |
| BR0208353A (pt) | Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças | |
| BR0115036A (pt) | Processo para a preparação de um composto | |
| ATE308328T1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
| PT1030667E (pt) | Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono | |
| BR0012169A (pt) | Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia | |
| FI962550A0 (fi) | Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa | |
| BR9908825A (pt) | Forma cristalina de paroxetina | |
| TR200101693T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
| SE9802209D0 (sv) | Novel compounds | |
| ES2088877T3 (es) | Procedimiento de preparacion del 3-pirrolidinol. | |
| DK1152757T3 (da) | MMP-inhibitorer i bindevævsblödhed | |
| AP2000001937A0 (en) | Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |